Ballentine Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,946	Closed	-$272K	–	429
2017 Q3	$272K	Sell	1,946 -9	-0.5%	-$1.26K	0.02%	287
2017 Q2	$253K	Buy	+1,955	New	+$253K	0.02%	302
2016 Q2	–	Sell	-1,638	Closed	-$228K	–	244
2016 Q1	$228K	Buy	+1,638	New	+$228K	0.02%	179